Skip to main content
MedPath Trial logoMedPath TrialMedPath Trial Home
Clinical Trials/CTRI/2018/12/016729
CTRI/2018/12/016729CompletedNot Applicable

Utilization of cartridge based nucelic acid amplification test for presumptive Tuberculosis diagnosis in urban Tumakuru

Sphoorthi Narasimhan1 site in 1 country52 target enrollmentStarted: January 1, 2019Last updated:
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit

Trial Snapshot

Phase
Not Applicable
Status
Completed
Sponsor
Enrollment
52
Locations
1
Primary Endpoint
To assess the utilization of CB NAAT pattern for presumptive diagnosis for drug resistance in tuberculosis in urban Tumakuru
Study OverviewEligibility CriteriaOutcomesInvestigatorsSitesRecords & IdentifiersSimilar Trials

Study Overview

Brief Summary

aim of the study is to assess the utilization of CB NAATpattern for presumptive diagnosis for drug resistance in tuberculosis in urbanTumakuru. complete enumeration of all techinician operating CB NAAT, lab technician, hospital manager and medical officer in case of absenece of lab technician to answer about the utilization of CB NAAT. the outcome of the study is to understand the utilization pattern of CB NAAT.

Study Design

Study Type
Observational

Eligibility Criteria

Ages
18.00 Year(s) to 60.00 Year(s) (—)
Sex
All

Inclusion Criteria

  • •CB NAAT operating Technician, lab technician, hospital manager, and medical officer.

Exclusion Criteria

  • Not provided

Outcomes

Primary Outcomes

To assess the utilization of CB NAAT pattern for presumptive diagnosis for drug resistance in tuberculosis in urban Tumakuru

Time Frame: last week of april

Secondary Outcomes

  • To assess the utilization of CB NAAT pattern for presumptive diagnosis for drug resistance in tuberculosis in urban Tumakuru(last week of april)

Investigators

Sponsor
Sphoorthi Narasimhan
Sponsor Class
Other [SELF ]

Study Sites (1)

Loading locations...

Similar Trials

Completed
Not Applicable
Utility of CB-NAAT (a diagnostic test) in diagnosing cases of skin tuberculosis.
CTRI/2019/02/017549King Georges Medical University35
Completed
Not Applicable
Nucleic Acid Amplification Testing (NAT) of Blood Donors for HCV and HIVHIV InfectionHepatitis C
NCT00004846National Institutes of Health Clinical Center (CC)30,000
Recruiting
Unknown
Stool CBNAAT Test for Pediatric Abdominal Tuberculosis
CTRI/2023/05/052525niversity College of Medical Sciences
Completed
Not Applicable
tility of CB-NAAT (a diagnostic test) in diagnosing cases of skin tuberculosis.
CTRI/2019/02/017549King Georges Medical University44
Completed
Not Applicable
sefullness of new rapid tool called Cartridge Based Nucelic Acid Amplification Test for diagnosis of tuberculosis in urban tumakuru
CTRI/2018/12/016729Sphoorthi Narasimhan43